Poznámky k epizodě
Dr. John Maraganore, founding CEO of Alnylam Pharmaceuticals and co-founder of City Therapeutics, discusses his journey from a Greek immigrant household to pioneering RNA interference (RNAi) therapeutics. He highlights Alnylam’s growth from a startup to a major biotech company, leading to the first FDA-approved RNAi therapy. John shares insights on decision-making, mentorship, and the future of RNA therapies. He also discusses his new ventures, including Corsera Health, focusing on cardiovascular disease prevention using RNAi.
* John shares his upbringing in Chicago, growing up with Greek…
Web: hbcpulse.substack.com

